Inhaled Vaccines for the Prevention of Tuberculosis

Garcia Contreras L¹, Awashthi S¹, Hanif SNM¹ and Hickey AJ^2,3*

¹Department of Pharmaceutical Sciences, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73126-0901, USA

²Division of Molecular Pharmaceutics, University of North Carolina at Chapel Hill, NC 27599-7571, USA

³RTI International, 3040 Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709-2194, USA

^*Corresponding Author: Hickey AJ, Division of Molecular Pharmaceutics, Research Triangle Institute, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA, Tel: 919-541-6771, Fax: 919-541-6936 Email:

Keywords: Dry Powder; Formulation; Inhaled Vaccines; Tuberculosis

Introduction